HWN Suggests

Bad Grades for Gleason

Despite our attempts to keep pace with our growing understanding of the disease, both pathologists and clinicians agree that there are significant deficiencies with the Gleason scale. For instance, the grading system ranges from 2 to 10, yet 6 is the lowest score currently assigned. When patients are told that they have a Gleason score 6 out of 10, they hear that they have a more aggressive cancer and an intermediate prognosis – and, understandably, that frightens them. Every day, I talk to patients whose cases have been sent to me in consultation, and if they have a Gleason 6 cancer, I first say, “That’s the best grade you can have,” hoping to allay precisely that concern.

read full article

Featured

 What Does a Gleason Score of 9 Mean? Understanding Biden’s Prostate Cancer Diagnosis

The NCI defines the Gleason score as a way to describe prostate cancer depending on “how abnormal the cancer cells in a biopsy sample look under a microscope and how quickly they are likely to grow and spread.” It is “used to help plan treatment and determine prognosis (outcome).” The Gleason score is calculated by adding the grades, the measures of that abnormality, of the two types of cells that make up the largest portion of the biopsied prostate tissue. A Gleason score usually ranges from 6 to 10, with a lower Gleason score meaning the cells look more normal and are likely to grow and spread slowly.

 What does the Gleason score mean?

To determine your prostate cancer Gleason score, ten to twelve samples of the tumor tissue core may be extracted during a prostate biopsy to observe these microscopic patterns. The goal here is to facilitate the grading and staging of your prostate cancer, helping clinicians to predict your prognosis and pick the best treatment for you based on past data.

Articles of Interest

One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading

Fifty years ago, Donald Gleason published his eponymous grading system and demonstrated its prognostic utility in clinical trials designed to investigate hormonal therapies for prostate cancer. Over the ensuing decades, the Gleason system has been widely used in clinical practice and research, and has been endorsed as the global grading standard for prostate cancer by numerous organizations, including the World Health Organization (WHO) and the Union for International Cancer Control (UICC). The diagnosis and treatment of prostate cancer has changed dramatically in recent decades and as the new millennium dawned, a modernization of the Gleason system commenced.

A Gleason Score of 7: Why is it So Important?

The Gleason score is often an indicator of whether it’s time to start prostate cancer treatment. When prostate cancer is caught early from regular screening, treatment isn’t always recommended right away. These men can often monitor the cancer closely through regular follow-up tests, avoiding the side effects that can come with treatment until the cancer has started to progress. This can take years for some men! Alternatively, if the Gleason score is higher than 7 it’s most likely time to begin treatments. But for men with a score of 7, it’s how they arrive at the score that plays a role in whether treatments should begin.

Gleason 6 prostate cancer: That which cannot be named

There is an ongoing debate regarding whether low-grade cancers, such as Gleason score 6 prostate cancer, should be called cancer... The correct strategy is to acknowledge that the patient has prostate cancer, to combine the Gleason score 6 with other severity of illness at diagnosis prognostic factors, to incorporate that knowledge into shared decision making, and to continue to work to discover molecular biomarkers.

Gleason Score 4+3: What It Means & Next Steps

The new, ISUP prostate grading system expands on the Gleason grading system and provides a more simplified grouping. In the Gleason system, a grade of 2-10 can be assigned, with 6 being the lowest grade that defines cancer. The ISUP grading system includes only 5 grade groups, all describing cancer, and starts with Grade Group 1. Starting the grading system at 1 instead of 6 can reduce the overtreatment of less aggressive disease.

Grade Groups of prostate cancer

The pathologist grades each sample of prostate cancer cells based on how quickly they are likely to grow or how aggressive the cells look. There are 5 Grade Groups. Grade Group 1 is the least aggressive and Grade Group 5 is the most aggressive. You may also hear about a score called the Gleason score. The Grade Group has now replaced the Gleason grade as doctors think the Grade Group is a more accurate way to grade prostate cancer cells. We have included the Gleason score because people still ask us about this.

Prognosis of Gleason Score 9–10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Whether the prognostic differences between Gleason scores 4 + 5, 5 + 4, and 5 + 5 warrant different treatment remains to be investigated; however, our findings indicate that the information loss by grouping of Gleason scores may obscure important outcome differences and thus possibly lead to over- or under-treatment. Thus, the reporting of Gleason scores including the Gleason pattern components is essential since collapsing the scores into groups entails loss of information.

Prostate Cancer Grading & Prognostic Scoring

Since prostate tumors are often made up of cancerous cells that have different grades, two grades are assigned for each patient. A primary grade is given to describe the cells that make up the largest area of the tumor and a secondary grade is given to describe the cells of the next largest area. For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. If the cancer is almost entirely made up of cells with the same score, the grade for that area is counted twice to calculated the total Gleason Score.

Prostate Cancer Pathology: Gleason Score and Tumor Stages

Gleason grading is based on assessing the glandular morphology at a relatively low magnification. The cytological properties of the cells (nuclear size and shape) are not judged. The various existing gland architectures are assigned to a Gleason pattern with values between 1–5

What is my prostate cancer grade?

The grade of your cancer is determined by looking at the tumor cells from the biopsy under a microscope. The prostate cancer grade is described using the Gleason score. This score is used to estimate how aggressive the cancer may be—if and how quickly the tumor may grow and spread. The pathologist assigns a number to the cells based on how abnormal they appear. The scale goes from 1 (non-aggressive) to 5 (very aggressive). The numbers of the two most common patterns are added together to create a Gleason Score. The Gleason grading system is one of the most important prognostic factors (that will help determine outcomes) in prostate cancer. The Grade Group is a more recent grading system and is intended to be simpler than the Gleason score. It has five grades - 1 through 5. You might see one of, or both the Gleason score and Grade Group, listed on a hospital pathology report.

What is the prognosis for recurrent prostate cancer with a Gleason score of 4+3 (Gleason score), indicating moderately to highly differentiated adenocarcinoma?

The prognosis for recurrent prostate cancer with a Gleason score of 4+3 is generally guarded, with a 5-year survival rate of approximately 70-80% after recurrence, and treatment options including salvage radiation therapy and systemic therapy with androgen deprivation therapy (ADT) and newer agents like abiraterone or enzalutamide.

Your Gleason Score & ISUP Grade

The ISUP (International Society of Urological Pathology) Grade is a newer, easier to understand and more accurate system at predicting how quickly your cancer might spread. It is done using prostate biopsy samples. The ISUP Grade uses a 1 to 5 grade group system. The higher the grade group, the higher the risk of your cancer being aggressive and spreading rapidly.

Resources

Prostate Cancer Gleason Score

When abnormal results are discovered from prostate cancer screen tests, the Digital Rectal Exam and PSA Blood Test, a biopsy may be recommended. The Gleason Score is the rating system assigned to the results of the biopsy. This type of biopsy is normally performed using transrectal ultrasound guidance. The ultrasound allows the physician to take distributed samples from the prostate. Typically twelve separate samples are taken. A pathologist will then examine the tissue samples under a microscope to determine whether or not the prostate contains cancerous tissue. A grade is assigned to the tissue samples. The two most common grades are added together to create the Gleason Score.

The Gleason Score

The Gleason scoring system is the most common Prostate Cancer grading system used... The Gleason score in addition to the Cancer Stage are a major key to determine treatment options. For example, Active Surveillance – repeating MRIs perhaps yearly to monitor the cancer – is suitable for lower scores. Patients with a higher Gleason score may need treatment that is more intensive, even if the cancer is not large or has not spread. Gleason scores of 5 indicate very low risk. A Gleason score is 6, is a low-grade cancer. A Gleason score of 7 is a medium-grade cancer, and a score of 8, 9, or 10 is a high-grade cancer. A lower-grade cancer grows more slowly and is less likely to spread than a high-grade cancer.

For prostate cancer patients, it’s always good to know the score

“Prostate cancer has more data points than other cancers,” he continued. “If you have early prostate cancer, say a score of 6, depending on the presence of co-morbidities or surgical risk, you may just need active surveillance. If you’re a 9 or 10 with metastatic disease, you will most likely need to take hormones or undergo an orchiectomy (surgical removal of the testicles) to control hormone production because the tumor has already spread beyond the prostate. If your score is in-between, you and your oncologist have to decide how to proceed.”